8-K - Prelude Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. On February 3, 2026 Prelude Therapeutics Incorporated (the "Company") issued a press release announcing that the U.S. Food and Drug Ad

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated February 3, 2026 104 Cover Page Interactive Data File (embed

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1